Biogen CEO To Step Down; Drugmaker Pulls Back On Alzheimer's Drug Aduhelm

Biogen CEO To Step Down; Drugmaker Pulls Back On Alzheimer’s Drug Aduhelm

By Mrinalika Roy and Leroy Leo (Reuters) – Biogen Inc said on Tuesday that Chief Executive Michel Vounatsos will step down and that the company is pulling back on selling its Alzheimer’s drug Aduhelm after the U.S. government’s Medicare program restricted coverage of the controversial treatment to patients in clinical trials. Vounatsos, who was named…

Read More
Ex-Tesla Engineer Aims To Build Next-generation Battery Materials In U.S.

Ex-Tesla Engineer Aims To Build Next-generation Battery Materials In U.S.

By Hyunjoo Jin SAN FRANCISCO (Reuters) – A battery startup founded by a former Tesla engineer announced on Tuesday plans for U.S.-based mass production of next-generation materials aimed at cutting costs, boosting driving ranges and reducing the industry’s reliance on China. Sila Nanotechnologies will invest in the low hundreds of millions of dollars in a…

Read More